SMA at Eurordis’ multi-stakeholder symposium in Brussel

to improve patient access to rare disease therapies

Themselves with just 20% of patients across Europe accessing today’s only therapy, Spinraza™. Although some countries benefit from full access, others, not at all. SMA Europe

Publicerat av

Liz

Until those day, was my kiss of death been stronger than those of the devil. I like to ride through hellfire with him ,when I come out victorious afterwards. I'm strong and proud rheumatoid arthritis warrior Följ mig, tack! Liz - Fotoblogg Spelblogg